Leiv Lea is CFO at Corvus Pharmaceuticals, Inc. (CRVS). They have made 6 open-market trades across 2 companies since 2007, most recently 2022-12-14.
CIK 0000939012
6 open-market purchases totalling $461K since 2007, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRVS | BUY | 2022-12-13 | 2022-12-15 | $0.75 | $26K | -4.1% | +7.9% | -12.2% |
| CRVS | BUY | 2022-03-16 | 2022-03-17 | $1.56 | $131K | -6.9% | -23.0% | -43.1% |
| CRVS | BUY | 2019-06-06 | 2019-06-10 | $3.49 | $89K | -3.2% | +50.1% | +3.8% |
| CRVS | BUY | 2018-12-21 | 2018-12-27 | $4.15 | $205K | +30.9% | +17.6% | +21.2% |
| PCYC | BUY | 2007-08-22 | 2007-08-22 | $2.01 | $6K | N/A | N/A | N/A |
| PCYC | BUY | 2007-08-21 | 2007-08-22 | $2.02 | $4K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.